🧬 A Tiny Dose of CYDY — Countdown to ESMO - A New Series - 🗓 49 Days Until May 15th

🚨 Title: Stage 4. Terminal. Now Cancer-Free?! At 25¢?!

Let’s set the stage…

Stage 4 metastatic triple-negative breast cancer (mTNBC) is a death sentence.
It spreads fast. It ignores most treatments.
Once it hits your brain, lungs, or liver… you’re done.

📉 Median survival? Around 12 months.
📈 Long-term survival? Almost nonexistent.
🎯 Cure? Not a thing.

So what if I told you a company trading for 25¢ just treated 30 of these terminal patients…
…and now says a subgroup is 36+ months out, alive and cancer-free?

You read that right.
No cancer. No progression. No recurrence.

🧪 The drug? Leronlimab.
👨‍⚕️ The company? CytoDyn ($CYDY).
📍 The event? ESMO Breast Cancer Conference — May 15th.

This isn’t hype. It’s from their February press release:

That’s unheard of.
That’s not how stage 4 works.
That’s not supposed to happen — but it did.

And the world finds out what really happened 49 days from now.

👀 Until then…
Sit tight. Do your homework.

And check back tomorrow for your next Tiny Dose of CYDY.